LLY

SEC source: 0001415889-23-014136 · form4-10122023_041001.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,945,975

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $603.00 to $603.94, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), and (5) to this Form 4.

SEC source: 0000059478-23-000251 · wk-form4_1695241367.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,379

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000253 · wk-form4_1695241452.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,368

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000255 · wk-form4_1695241528.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,035

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000257 · wk-form4_1695241617.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,181

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000259 · wk-form4_1695241687.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,133

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000261 · wk-form4_1695241761.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,706

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000243 · wk-form4_1694636046.xml · nonDerivative · entry 2

Weems Alonzo · CIK 0001869672 · EVP, ERM & CECO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,000

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2023.

SEC source: 0000059478-23-000243 · wk-form4_1694636046.xml · nonDerivative · entry 1

Weems Alonzo · CIK 0001869672 · EVP, ERM & CECO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,760

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2023.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 11

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,983,810

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.90 to $575.88, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 10

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,987,310

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.89 to $574.86, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,998,645

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.89 to $573.88, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,045,073

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.89 to $572.88, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,105,999

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.89 to $571.885, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 6

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,133,848

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.58 to $570.57, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 5

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,144,260

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.55 to $569.35, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,159,518

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.55 to $568.54, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,174,496

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.53 to $567.495, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,181,878

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.53 to $566.525, inclusive.

SEC source: 0001415889-23-013115 · form4-09082023_040901.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,189,610

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.50 to $565.49, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), and (11) to this Form 4.

SEC source: 0000059478-23-000241 · wk-form4_1693598730.xml · nonDerivative · entry 1

Dozier Eric · CIK 0001955972 · EVP, HR & Diversity

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,262

F1 · shares: Reflects the gift of common stock to a charitable donor advised fund.

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,193,810

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.03 to $557.37, inclusive.

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,194,710

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.03 to $557.02, inclusive.

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,199,151

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.97, inclusive.

SEC source: 0001415889-23-012859 · form4-09012023_040902.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,207,457

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 4

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,240,351

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.06 to $557.57, inclusive.

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,241,251

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.02 to $556.25, inclusive.

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,241,707

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.01 to $555.83, inclusive.

SEC source: 0001415889-23-012835 · form4-08312023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,244,707

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.

SEC source: 0001415889-23-012799 · form4-08302023_040804.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,246,532

SEC source: 0001415889-23-012799 · form4-08302023_040804.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,246,832

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.97, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001415889-23-012748 · form4-08292023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,275,279

SEC source: 0001415889-23-012748 · form4-08292023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,275,779

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.98, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0001415889-23-012716 · form4-08282023_040801.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,312,939

SEC source: 0001415889-23-012716 · form4-08282023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,313,239

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.95, inclusive.

SEC source: 0001415889-23-012716 · form4-08282023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,321,766

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.965, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

SEC source: 0001415889-23-012661 · form4-08252023_040801.xml · nonDerivative · entry 3

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,376,511

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.065 to $556.47, inclusive.

SEC source: 0001415889-23-012661 · form4-08252023_040801.xml · nonDerivative · entry 2

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,379,811

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.02 to $556.00, inclusive.

SEC source: 0001415889-23-012661 · form4-08252023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,381,211

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.91, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4.

SEC source: 0001415889-23-012600 · form4-08242023_040801.xml · nonDerivative · entry 1

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,397,503

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.33 to $556.165, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

SEC source: 0000059478-23-000227 · wk-form4_1692735851.xml · nonDerivative · entry 1

Alvarez Ralph · CIK 0001310215 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,256

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000229 · wk-form4_1692735987.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,214

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000231 · wk-form4_1692736074.xml · nonDerivative · entry 1

Hedley Mary Lynne · CIK 0001340823 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,017

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000233 · wk-form4_1692736167.xml · nonDerivative · entry 1

JOHNSON KIMBERLY H · CIK 0001658089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,160

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000235 · wk-form4_1692736300.xml · nonDerivative · entry 1

LUCIANO JUAN R · CIK 0001455792 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,079

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000237 · wk-form4_1692736404.xml · nonDerivative · entry 1

Sulzberger Gabrielle · CIK 0001262388 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,694

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000239 · wk-form4_1692736474.xml · nonDerivative · entry 1

Zakrowski Donald A · CIK 0001561539 · SVP, Finance, & CAO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,378

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2022.

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 9

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,398,810

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $546.44 to $547.12, inclusive.

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 8

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,402,771

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $545.44 to $546.42, inclusive.

SEC source: 0001415889-23-012311 · form4-08162023_040802.xml · nonDerivative · entry 7

LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,415,137

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $544.44 to $545.43, inclusive.